Sanofi has made no secret of its desire to be at the forefront of the digital transformation of business, and the big pharma says it will now apply leading-edge real-world evidence (RWE) analytics being developed by the high-profile US start-up Aetion to its clinical trial process.
The venture-capital backed Aetion was founded by the Harvard Medical School faculty around four years ago, and recently attracted former...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?